Feed Additive Developer Signs MOU with Philippine Distributor
Source: Streetwise Reports  (12/17/19)
This is the first step toward a binding, definitive agreement between the two companies. More >

Animal Health Product Developer Lands First Sale in Malaysia
Source: Streetwise Reports  (12/15/19)
The maiden order comes on the heels of the country approving use of the product there. More >

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed
Source: Streetwise Reports  (11/26/19)
The highlights of this investment story are outlined in a Zacks Small-Cap Research report. More >

Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company
Source: Clive Maund for Streetwise Reports  (10/12/19)
Technical analyst Clive Maund believes this stock could gain traction soon. More >

Developer of Premix for Livestock Feed Lands Sizable Order from Asia
Source: Streetwise Reports  (8/26/19)
Demand for the Canadian company's product is growing in the Asia-Pacific region. More >

Small-Cap Logistics Company Partners with Aphria to Deliver Medical Cannabis
Source: Streetwise Reports  (8/22/19)
The initiative, to start in Calgary, is expected to expand rapidly into other cities. More >

Life Sciences Firm's OxC-beta Approved for Livestock Feed in Mexico
Source: Streetwise Reports  (8/21/19)
The country represents a significant market for feed consumption. More >

Shares of Plant-Based Meat Company Spike 53% (and It's Not Beyond Meat)
Source: Streetwise Reports  (5/6/19)
This small-cap nutrascience stock hit a new 52-week high on May 6th, extending a run that has the stock up 147% over a five-day period. More >

Canadian Life Sciences Firm Seeks Collaborative Cannabis Partner
Source: Streetwise Reports  (4/5/19)
This represents the company's expansion into another business area. More >

Livestock Feed Developer Partners to Initiate Product Sales in the U.S.
Source: Streetwise Reports  (2/22/19)
The arrangement represents this Canadian life sciences firm's entrée into a significant market. More >

Target Raised on Nutraceutical Firm After It Inks 'Marquee Partnership'
Source: Streetwise Reports  (1/9/19)
The agreement terms and benefits of the partnership to this pharmaceutical company were relayed in an H.C. Wainwright & Co. report. More >

Yields Over 9% and Discounts Up to 22% Make for Buys
Source: Adrian Day for Streetwise Reports  (12/10/18)
Money manager Adrian Day looks at several non-resource companies in his portfolio, most with very attractive dividend yields as high as more than 9%. More >

Three Small-Caps on This Fund Manager's List
Source: Streetwise Reports  (10/30/18)
Steve Palmer, founding partner, President and Chief Investment Officer of AlphaNorth Asset Management, talks with Streetwise Reports about several small-cap companies from three sectors that he has been following. More >

Update on Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed
Source: Clive Maund for Streetwise Reports  (10/29/18)
Technical analyst Clive Maund provides an update on a company whose product is replacing antibiotics for growth promotion in animal feed. More >

This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers
Source: Streetwise Reports  (10/27/18)
Multiple governments around the world have unleashed mandates on livestock feed regulations that pose an opportunity for a Canada-based biotech company. More >

Animal Health Product Developer to Expand Sales Footprint
Source: Streetwise Reports  (10/20/18)
This Canadian company makes progress with its commercial uptake efforts. More >

Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed
Source: Clive Maund for Streetwise Reports  (10/1/18)
As the worldwide movement to ban antibiotics as a growth promoter in animal feed gains traction, technical analyst Clive Maund has called an "immediate strong buy" on a company that has developed an alternative. More >

Life Sciences Company Hits Sales Milestone with Livestock Product
Source: Streetwise Reports  (9/29/18)
With this development, the Canadian firm entered a new geography and an additional market segment. More >

Life Science Company Sells Large Order of Non-Antibiotic Growth Promoter for Livestock
Source: Streetwise Reports  (9/25/18)
This is the second large shipment to the Philippine distributor. More >

Portfolio Manager's Biotech Watchlist Picks for 2018
Source: Streetwise Reports  (1/2/18)
StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this interview with The Life Sciences Report, portfolio manager Bruce Campbell highlights four companies that he is putting on Streetwise Reports' 2018 Biotech Watchlist.
More >

Cannabis Cultivator Poised to Profit When Recreational Marijuana Becomes Legal in Canada
Source: Lior Gantz for Streetwise Reports  (10/17/17)
With the Canadian cannabis market primed to be worth billions upon legalization of recreational marijuana use, Lior Gantz of Wealth Research Group makes the case for an "undervalued" competitor.
More >

The ASX: Investing in an Emerging Biotech Frontier
Source: Stuart Roberts for The Life Sciences Report  (8/10/16)
Concerned about investing in the life sciences in the United States, where markets have slumped in 2016 and the presidential election furthers volatility? NDF Research Founder Stuart Roberts makes an argument for taking a look at investment opportunities Down Under. More >

VANC Pharmaceuticals Could Earn 75% Net Margin with OTC Iron Supplement
Source: Nick Hodge, Outsider Club  (3/28/16)
On March 7, VANC Pharmaceuticals announced the launch of a new over-the-counter (OTC) iron supplement called Hema-Fer. As the company gears up to market Hema-Fer across Canada, it is important to understand that VANC sells two types of products: generic prescription drugs and over-the-counter products. More >

How to Get Your Piece of the Growing $186B Biomarine Industry: BICA's Pierre Erwes
Source: JT Long of The Life Sciences Report  (12/9/15)
Sustainable harvesting the bounty of the ocean for pharmaceutical, nutritional and cosmetic uses is big business—$186 billion per year and growing. In this interview with The Life Sciences Report, BioMarine International Clusters Association Chairman Pierre Erwes shares the names of some public and private biotech companies making waves in the blue economy. More >

The Big Picture: Edison's Pooya Hemami Looks Beyond Cancer for Biotech Winners
Source: Peter Byrne of The Life Sciences Report  (6/10/15)
Analyst Pooya Hemami of Edison Investment Research casts a wide net when it comes to investment opportunities in the life sciences. You name it, his universe includes it: artificial sweeteners, blood tests, sleep aids, cancer treatments, brain health. In this interview with The Life Sciences Report, Dr. Hemami reflects on the biotech market at midyear, and describes a robust basket of outstanding companies with pipeline treasures. More >